Inventor · disambiguated record
Richard Daifuku
Also filed as: DAIFUKU RICHARD
11 granted patents·7 pending applications·48 citations·filing 2002–2017
87Inventor score
Files withKORONIS PHARMACEUTICALS INC12EPIGENETICS PHARMA LLC3DAIFUKU RICHARD2KORONOS PHARMACEUTICALS INC1
Top patents by PatentIndex Score
18 records- 0192US7642247B21,3,5-triazines for treatment of viral diseasesKORONIS PHARMACEUTICALS INC·Filed 2007·Granted Jan 5, 2010·27 cites·14 claims
- 0283US7648967B2Mutagenic nucleoside analogs for the treatment of viral diseaseKORONIS PHARMACEUTICALS INC·Filed 2006·Granted Jan 19, 2010·2 cites·6 claims
- 0377US7244732B2Prodrugs of heteroaryl compoundsKORONIS PHARMACEUTICALS INC·Filed 2004·Granted Jul 17, 2007·9 cites·25 claims
- 0476US7982034B2Prodrugs of heteroaryl compoundsKORONIS PHARMACEUTICALS INC·Filed 2009·Granted Jul 19, 2011·2 cites·18 claims
- 0575US7589092B2Prodrugs of heteroaryl compoundsKORONIS PHARMACEUTICALS INC·Filed 2006·Granted Sep 15, 2009·3 cites·25 claims
- 0668US7772197B21,3,5-triazines for treatment of viral diseasesKORONIS PHARMACEUTICALS INC·Filed 2003·Granted Aug 10, 2010·3 cites·7 claims
- 0768US2009192099A1Prodrugs of heteroaryl compoundsKORONIS PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 0865US7244717B2Mutagenic nucleoside analogs for the treatment of viral diseaseKORONIS PHARMACEUTICALS INC·Filed 2002·Granted Jul 17, 2007·2 cites·6 claims
- 0959US2007219200A1Prodrugs of heteroaryl compoundsKORONOS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1057US8324379B2Prodrugs of heteroaryl compoundsDAIFUKU RICHARD·Filed 2011·Granted Dec 4, 2012·0 cites·9 claims
- 1157US2008009496A1Mutagenic heterocyclesKORONIS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1250US2008033172A1Mutagenic HeterocyclesKORONIS PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1348US9493500B2Fluorinated pyrimidine analogs and methods of use thereofDAIFUKU RICHARD·Filed 2013·Granted Nov 15, 2016·0 cites·22 claims
- 1448US2007207973A11,3,5-Triazines for Treatment of Viral DiseasesKORONIS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1547US2010279968A1Mutagenic Nucleoside Analogs for the Treatment of Viral DiseaseKORONIS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1646US10479807B2Silylated pyrimidine prodrugs and methods of their useEPIGENETICS PHARMA LLC·Filed 2015·Granted Nov 19, 2019·0 cites·11 claims
- 1733US2019054103A1Method of treatment of tp53 wild-type tumors with 2',2'-difluoro-5-aza-2'-deoxycytidine or prodrugs thereofEPIGENETICS PHARMA LLC·Filed 2017·Application pending·0 cites
- 1830US10071112B2Vitamin E-nucleoside prodrugsEPIGENETICS PHARMA LLC·Filed 2015·Granted Sep 11, 2018·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →